YBGJ — Yubo International Biotech Balance Sheet
0.000.00%
- $1.62m
- $1.62m
- $0.01m
Annual balance sheet for Yubo International Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.028 | 0.018 | 0.006 | 0.007 | 0.008 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.56 | 0.345 | 0.366 | 0.442 | 0.426 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.06 | 0.75 | 0.725 | 0.683 | 0.668 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.34 | 1.41 | 0.767 | 0.685 | 0.122 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 4.59 | 2.35 | 1.67 | 1.53 | 0.847 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.79 | 2.52 | 3.4 | 4.72 | 2.79 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.72 | 2.91 | 3.51 | 4.96 | 2.8 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.131 | -0.565 | -1.84 | -3.42 | -1.95 |
| Total Liabilities & Shareholders' Equity | 4.59 | 2.35 | 1.67 | 1.53 | 0.847 |
| Total Common Shares Outstanding |